scispace - formally typeset
Open AccessJournal Article

Measurement of Antibodies to Herpesvirus Types 1 and 2 in Human Sera

William E. Rawls, +3 more
- 01 Mar 1970 - 
- Vol. 104, Iss: 3, pp 599-606
Reads0
Chats0
TLDR
When varying dilutions of human sera were mixed with constant amounts of the two types of herpesvirus, it was observed that either type 1 virus was neutralized at a greater serum dilution than type 2, or the two kinds were neutralized equally well as mentioned in this paper.
Abstract
When varying dilutions of human sera were mixed with constant amounts of the two types of herpesvirus, it was observed that either type 1 virus was neutralized at a greater serum dilution than type 2, type 2 was neutralized at a greater serum dilution than type 1, or the two types were neutralized equally well. The relative antibody titer of type 2 virus to type 1 virus was found to correlate with the location of herpetic lesions experienced by the patients. When the ratio was expressed as an index (II/I index), sera from persons with oral herpesvirus type 1 infections, for the most part, yielded values of less than 85 whereas sera from persons with genital herpesvirus type 2 infections yielded values of 85 or greater. The same relationship was demonstrated using either the plaque-reduction or the microneutralization test. The plaque-reduction test, microneutralization test and neutralization kinetics test were compared by analyzing a group of sera for herpesvirus type 2 antibodies by all three methods. There was agreement between the three methods in 83% to 89% of the determinations. Thus antibodies to the two herpesviruses can be quantitated in the same serum by neutralization techniques employing varying serum dilutions and a constant amount of virus, and the same antibody activity is measured as in the neutralization kinetics test.

read more

Citations
More filters
Journal ArticleDOI

Genital herpes simplex virus infections: clinical manifestations, course, and complications.

TL;DR: The clinical course and complications of 268 patients with first episodes and 362 with recurrent episodes of genital herpes infection were reviewed, and the major concerns were the frequency of recurrences and fear of transmitting infection to partners or infants.
Journal ArticleDOI

Risk of recurrence after first episodes of genital herpes. Relation to HSV type and antibody response.

TL;DR: Risk factors associated with recurrent genital herpes-simplex-virus infection caused by either Type 1 or 2 herpesvirus (HSV-1 or HSV-2) were defined and recurrences were more likely to follow an index recurrent episode than an index first episode, whether primary or nonprimary, and were morelikely to occur in men than in women.
Journal ArticleDOI

Treatment of first episodes of genital herpes simplex virus infection with oral acyclovir. A randomized double-blind controlled trial in normal subjects.

TL;DR: A double-blind placebo-controlled trial of oral acyclovir in the treatment of first episodes of genital herpes simplex virus infections in 48 young adults found it to be safe and effective in both women and men.
Journal ArticleDOI

A trial of topical acyclovir in genital herpes simplex virus infections

TL;DR: Topical acyclovir shortens the duration of viral shedding and accelerates healing of some genital herpes simplex virus infections and had no effect on the symptoms or healing times in women.
Journal ArticleDOI

Intravenous acyclovir for the treatment of primary genital herpes

TL;DR: Intravenous acyclovir substantially decreases the symptoms, duration of lesions, and complications of primary genital herpes.
Related Papers (5)